Seamus Mulligan
Director/Board Member bei JAZZ PHARMACEUTICALS PLC
Vermögen: 142 Mio $ am 31.03.2024
Profil
Seamus C.
Mulligan was the founder and had founded Azur Pharma Ltd.
in 2005, where he served as Chairman & Chief Executive Officer until 2012.
Currently, he holds the position of Independent Director at Jazz Pharmaceuticals, Inc. since 2012 and at Jazz Pharmaceuticals Plc since 2013.
In his former roles, he was Chairman & Chief Executive Officer at Emergent BioSolutions Ireland Ltd.
from 2014 to 2018, Executive Chairman at Circ Pharma Ltd.
from 2006 to 2017, and Director at Emergent BioSolutions, Inc. from 2019 to 2020.
Additionally, he held the position of Executive VP-Business & Corporate Development at Elan Corp.
Plc from 1984 to 2004.
Mr. Mulligan's education includes undergraduate and graduate degrees from Trinity College Dublin.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.08.2023 | 1 172 375 ( 1,88% ) | 141 Mio $ | 31.03.2024 | |
ADVANCED ONCOTHERAPY PLC
5,60% | 03.05.2023 | 30 405 721 ( 5,60% ) | 677 135 $ | 31.08.2023 |
Aktive Positionen von Seamus Mulligan
| Unternehmen | Position | Beginn |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Director/Board Member | 18.01.2012 |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Director/Board Member | 01.01.2012 |
Ehemalige bekannte Positionen von Seamus Mulligan
| Unternehmen | Position | Ende |
|---|---|---|
| EMERGENT BIOSOLUTIONS INC. | Director/Board Member | 21.05.2020 |
Emergent BioSolutions Ireland Ltd.
 Emergent BioSolutions Ireland Ltd. Pharmaceuticals: MajorHealth Technology Adapt Pharma Ltd. develops and distributes therapeutic treatments. The company was founded by David Brabazon and is headquartered in Dublin, Ireland. | Chief Executive Officer | 01.10.2018 |
Circ Pharma Ltd.
 Circ Pharma Ltd. Pharmaceuticals: MajorHealth Technology Circ Pharma Ltd. develops pharmaceutical products. It offers cardiovasculars and pain & neurology products. The firm has a technology in the areas of chronotherapeutic drug delivery and pipeline of novel products. The company was founded by Seamus Mulligan in 2006 and is headquartered in Dublin, Ireland. | Chairman | 01.04.2017 |
Azur Pharma Ltd.
 Azur Pharma Ltd. Pharmaceuticals: MajorHealth Technology Azur Pharma Ltd. manufactures pharmaceutical products. It offers branded generic prescription drugs, antibiotics and medicines in multiple therapeutic areas. The company was founded in May, 2005 and is headquartered in Dublin, IE | Chief Executive Officer | 26.01.2012 |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | 01.01.2004 |
Ausbildung von Seamus Mulligan
| Trinity College Dublin | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| EMERGENT BIOSOLUTIONS INC. | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Azur Pharma Ltd.
Azur Pharma Ltd. Pharmaceuticals: MajorHealth Technology Azur Pharma Ltd. manufactures pharmaceutical products. It offers branded generic prescription drugs, antibiotics and medicines in multiple therapeutic areas. The company was founded in May, 2005 and is headquartered in Dublin, IE | Health Technology |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Commercial Services |
Circ Pharma Ltd.
Circ Pharma Ltd. Pharmaceuticals: MajorHealth Technology Circ Pharma Ltd. develops pharmaceutical products. It offers cardiovasculars and pain & neurology products. The firm has a technology in the areas of chronotherapeutic drug delivery and pipeline of novel products. The company was founded by Seamus Mulligan in 2006 and is headquartered in Dublin, Ireland. | Health Technology |
Emergent BioSolutions Ireland Ltd.
Emergent BioSolutions Ireland Ltd. Pharmaceuticals: MajorHealth Technology Adapt Pharma Ltd. develops and distributes therapeutic treatments. The company was founded by David Brabazon and is headquartered in Dublin, Ireland. | Health Technology |
